e-learning
resources
Virtual 2020
Wednesday, 09.09.2020
Tuberculosis: part 2
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Preliminary evaluation of serial interferon-gamma releasing assay testing in NSCLC patients treated with immune checkpoint inhibitors
K. Fujita (Kyoto, Japan), Y. Yamamoto (Kyoto, Japan), O. Kanai (Kyoto, Japan), M. Okamura (Kyoto, Japan), K. Nakatani (Kyoto, Japan), T. Mio (Kyoto, Japan)
Source:
Virtual Congress 2020 – Tuberculosis: part 2
Session:
Tuberculosis: part 2
Session type:
Oral Presentation
Number:
5298
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Fujita (Kyoto, Japan), Y. Yamamoto (Kyoto, Japan), O. Kanai (Kyoto, Japan), M. Okamura (Kyoto, Japan), K. Nakatani (Kyoto, Japan), T. Mio (Kyoto, Japan). Preliminary evaluation of serial interferon-gamma releasing assay testing in NSCLC patients treated with immune checkpoint inhibitors. 5298
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Expert interview: Microbiologists on tuberculosis diagnostics
Related content which might interest you:
Evaluation of serial interferon-gamma release assay testing in lung cancer patients treated with immune checkpoint inhibitors
Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis
Year: 2021
Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Predictive biomarker of immune checkpoint inhibitors efficacy
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019
The role of fibrocyte-like cells in combination treatment of immune checkpoint inhibitor with antiangiogenic agents
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020
An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy
Source: Eur Respir J 2014; 44: 1369-1372
Year: 2014
Dynamic monitoring of EGFR mutations in circulating tumor DNA for early detection of drug resistance in NSCLC patients on EGFR-TKI therapy
Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer
Year: 2019
Use of immune cell function assay in immune surveillance of lung transplant recipients: Correlations with clinical outcome and other immune assays
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
The clinical benefits of immune checkpoint inhibitors for thymic carcinomas
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018
Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Serial interferon-gamma release assay in children with tuberculosis infection
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Sequential analysis of interferon-γ release assay results in active tuberculosis patients
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Clinical evaluation of two interferon-gamma release assay tests for immunocompromised patients
Source: Annual Congress 2010 - Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
Year: 2010
The predictive value of circulating tumor DNA dynamics in plasma of EGFR-mutation-positive NSCLC patients on first line tyrosine kinase inhibitors
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
The efficacy of immune checkpoint inhibitors in thoracic malignancies
Source: Eur Respir Rev, 30 (162) 200387; 10.1183/16000617.0387-2020
Year: 2021
CellCollector®: A novel method for the isolation of circulating tumor cells (CTC) in vivo and ex vivo in lung cancer patients during therapy
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs
Source: Eur Respir J 2009; 34: 702
Year: 2009
Support of ex vivo IFN-gamma release assays in the diagnosis of tuberculosis infection in HIV/AIDS patients
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Immune checkpoint inhibitors in lung cancer
Source: International Congress 2016 – GR3 Scientific Grand Round: precision medicine
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept